Drug shortage
Pilocarpine Hydrochloride Ophthalmic Solution · AbbVie Inc.
FDA drug shortage · To Be Discontinued · updated Mar 24, 2026
Key facts
| Generic name | Pilocarpine Hydrochloride Ophthalmic Solution |
|---|---|
| Company | AbbVie Inc. |
| Presentation | Vuity, Ophthalmic Solution, 12.5 mg/1 mL (NDC 0074-7098-04) |
| Dosage form | Ophthalmic Solution |
| Status | To Be Discontinued |
| Therapeutic category | Ophthalmology |
| Package NDCs | 0074-7098-04 |
| First posted | Mar 24, 2026 |
| Last updated | Mar 24, 2026 |
| Discontinued | Mar 24, 2026 |
At a glance
- 1–9 Package NDCs affected
- 1–9 FDA shortage records for this drug
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug shortages
The FDA Drug Shortages Database lists current and resolved shortages of drugs, with presentations, affected NDCs and reasons reported by manufacturers.
Source: U.S. Food and Drug Administration (FDA), Drug Shortages Database · Source date: